This review evaluates the interplay between melatonin and PRL signaling in mammary oncogenesis, with particular emphasis on melatonin's potential to modulate PRL-driven tumor progression through endocrine and paracrine mechanisms. This evidence concerns the gene PRL and neoplasm.